Non-steroidal anti-inflammatory drugs and benign oesophageal stricture.
Simon Heller(University of Sheffield), Mark A. Atkinson(University of Florida), I W Fellows(Queen's Medical Centre), A L Ogilvie(Arrowe Park Hospital)
Cited by 106
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k